Evolus Stock

Evolus EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Evolus (EOLS) as of Aug 8, 2026 is -5.32. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -17.41 — a change of -69.43% (higher).

EV/OCF

-5.32

YoY

-69.43%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Evolus is 2026 -5.32 . EV/OCF (Enterprise Value to Operating Cash Flow) of Evolus was 2025 -17.41 . It decreases by -69.43% higher compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Evolus is -5.32 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Evolus changed from -17.41 to -5.32, representing a -69.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Evolus since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Evolus

All Key Metrics — Evolus